• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Lyncean Technologies receives $650,000 in Series A funding

Bioengineer by Bioengineer
December 9, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Lyncean Technologies, Inc., manufacturer of the Lyncean Compact Light Source, today announced the successful raising of $650,000 in a Series A funding round. The funding will be used to further grow commercial activity in the academic research market and the exploration of vertical market opportunities in the semiconductor and healthcare fields.

"Our recent sales and marketing efforts have validated our belief that world-class researchers value the ability to conduct synchrotron quality experiments in their own laboratory and we need to be ready to support the expected business operationally," said Lyncean CEO Dr. Michael Feser. "Having the additional financial support will also help us begin to execute our vision of expanding into one of several potential vertical markets."

"X-ray based technologies are playing a growing role not only in scientific applications but also in industrial and medical applications. We see tremendous opportunity for the Lyncean Compact Light Source to enable more important, high-value solutions for industry." said Lucian Wagner, General Partner at EuroUS Ventures, who coordinated and lead the group of participating investors.

###

About the Company

Lyncean Technologies, Inc. is located in Fremont, California and was founded in 2001 to develop the Compact Light Source (CLS), a miniature synchrotron x-ray source based on research performed at the SLAC National Accelerator Laboratory and Stanford University. Unlike stadium-sized synchrotron radiation sources that require a highly technical support staff, the CLS fits in a typical laboratory space and is designed to be operated directly by academic or industrial end-users. By replacing the conventional "undulator" magnets found in the large synchrotrons by laser technology, the entire device scales down in size by a factor of 200. Unlike traditional laboratory sources, the CLS makes a narrow beam of nearly monochromatic X-rays which are adjustable in energy. The first commercial Lyncean CLS was purchased in December 2012 by researchers from the newly formed Center for Advanced Laser Applications in Germany, a joint project of the Ludwig Maximilians University of Munich and the Technical University Munich (TUM). The Munich CLS was delivered at the end of 2014 and has been in routine operation since April 2015. For more information visit: http://www.lynceantech.com

Media Contact

Jack Kasahara
[email protected]

http://www.lynceantech.com

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Patient Insights: MyChart’s Role in IUD Placement

November 1, 2025
blank

Reevaluating Xylotini: Codon Bias and Phylogenetic Insights

November 1, 2025

Delayed Cord Clamping Reduces Bronchopulmonary Dysplasia Risk

November 1, 2025

Nicotine Mitigates Early Neurodegeneration Through Autophagic Enhancement

November 1, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1294 shares
    Share 517 Tweet 323
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    312 shares
    Share 125 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    203 shares
    Share 81 Tweet 51
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    136 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Patient Insights: MyChart’s Role in IUD Placement

Reevaluating Xylotini: Codon Bias and Phylogenetic Insights

Delayed Cord Clamping Reduces Bronchopulmonary Dysplasia Risk

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.